AGENUS INC — Form 8-K
Filed August 18, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
On August 12, 2026, Agenus Inc. entered into a material definitive agreement (Item 1.01) and created a direct financial obligation or off-balance sheet arrangement (Item 2.03). The company also conducted an unregistered sale of equity securities (Item 3.02). Specific counterparties, dollar amounts, share counts, and terms are not disclosed in this 8-K header filing.
Why this rating
Material agreement + equity issuance is meaningful for $135M biotech, but absence of concrete terms prevents full assessment. Needs 10-Q/full exhibit review.
Extracted items
- 1.01 material agreement
- 2.03 material obligation
- 3.02
See more from August 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.